
Ikaria Group
Ikaria Group is a venture capital firm based in Hong Kong, Hong Kong. This profile covers what we know about Ikaria Group and how founders can get in front of it in 2026.
Ikaria Group is an investment company that provides capital and investment for public and private technology companies.
- Location
- Hong Kong, Hong Kong
- Team size
- 11-50
How to pitch Ikaria Group
The founders who hear back from Ikaria Group lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Ikaria Group
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Ikaria Group." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/ikaria-group
Frequently Asked Questions
What is Ikaria Group?
Ikaria Group is a venture capital firm based in Hong Kong, Hong Kong. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Ikaria Group based?
Ikaria Group is based in Hong Kong, Hong Kong. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Ikaria Group?
Unlock a verified email for Ikaria Group and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.